ANTHONY DIGIANDOMENICO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANTHONY DIGIANDOMENICO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTHONY DIGIANDOMENICO. ANTHONY DIGIANDOMENICO is Director in Cue Biopharma, Inc. ($CUE) and in ENDRA Life Sciences Inc. ($NDRA) and Director in ENDRA Life Sciences Inc. ($NDRA) and Director in Provention Bio, Inc. ($PRVB).
Latest Insider Trading Transactions of ANTHONY DIGIANDOMENICO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CUE, NDRA, PRVB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2021 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Jul 23 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | X | 0.87 | 100,503 | 87,438 | 0 | |
| Jul 23 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | X | 0.87 | 100,503 | 87,438 | 382,012 | 281.5 K to 382 K (+35.70 %) |
| Jun 09 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 0.92 | 5,000 | 4,600 | 281,509 | 276.5 K to 281.5 K (+1.81 %) |
| May 29 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 0.90 | 5,000 | 4,500 | 276,509 | 271.5 K to 276.5 K (+1.84 %) |
| May 26 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 0.78 | 10,000 | 7,800 | 252,083 | 242.1 K to 252.1 K (+4.13 %) |
| Apr 13 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Grant | A | 0.00 | 42,857 | 0 | 242,083 | 199.2 K to 242.1 K (+21.51 %) |
| Jan 06 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 1.90 | 12,000 | 22,800 | 12,000 | |
| Dec 11 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 0.87 | 100,503 | 87,438 | 100,503 | |
| Dec 11 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 0.90 | 89,585 | 80,627 | 89,585 | |
| Dec 11 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Grant | A | 0.87 | 100,503 | 87,438 | 199,226 | 98.7 K to 199.2 K (+101.80 %) |
| Dec 06 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | J | 0.00 | 342,000 | 0 | 520,712 | 178.7 K to 520.7 K (+191.37 %) |
| Sep 30 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 6.83 | 30,000 | 204,900 | 178,712 | 148.7 K to 178.7 K (+20.17 %) |
| Sep 26 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 8.44 | 5,000 | 42,200 | 148,712 | 143.7 K to 148.7 K (+3.48 %) |
| Sep 25 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 8.39 | 5,000 | 41,950 | 143,712 | 138.7 K to 143.7 K (+3.60 %) |
| Aug 09 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 9.09 | 10,000 | 90,900 | 138,712 | 128.7 K to 138.7 K (+7.77 %) |
| Jun 25 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 12.54 | 24,000 | 300,960 | 24,000 | |
| Jun 20 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 10.96 | 10,000 | 109,600 | 128,712 | 118.7 K to 128.7 K (+8.42 %) |
| Jun 18 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 10.88 | 10,000 | 108,800 | 118,712 | 108.7 K to 118.7 K (+9.20 %) |
| Jun 17 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 12.16 | 25,000 | 304,000 | 108,712 | 83.7 K to 108.7 K (+29.86 %) |
| Mar 27 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 3.09 | 50,000 | 154,500 | 50,000 | |
| Jan 04 2019 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.81 | 10,000 | 48,100 | 30,000 | 20 K to 30 K (+50.00 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.76 | 10,000 | 17,600 | 83,712 | 73.7 K to 83.7 K (+13.57 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.76 | 10,000 | 17,600 | 83,712 | 73.7 K to 83.7 K (+13.57 %) |
| Dec 28 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.95 | 20,000 | 39,000 | 73,712 | 53.7 K to 73.7 K (+37.24 %) |
| Dec 28 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.77 | 20,000 | 95,400 | 50,000 | 30 K to 50 K (+66.67 %) |
| Dec 28 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.77 | 20,000 | 95,400 | 50,000 | 30 K to 50 K (+66.67 %) |
| Dec 27 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.92 | 17,270 | 33,158 | 53,712 | 36.4 K to 53.7 K (+47.39 %) |
| Dec 26 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.85 | 2,000 | 3,700 | 36,442 | 34.4 K to 36.4 K (+5.81 %) |
| Dec 26 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.49 | 10,000 | 44,900 | 20,000 | 10 K to 20 K (+100.00 %) |
| Dec 21 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.96 | 5,000 | 9,800 | 34,442 | 29.4 K to 34.4 K (+16.98 %) |
| Dec 18 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 5.48 | 10,000 | 54,800 | 10,000 | 0 to 10 K |
| Dec 06 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.45 | 4,442 | 10,883 | 29,442 | 25 K to 29.4 K (+17.77 %) |
| Dec 03 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.45 | 4,849 | 11,880 | 25,000 | 20.2 K to 25 K (+24.06 %) |
| Dec 03 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.47 | 151 | 373 | 20,151 | 20 K to 20.2 K (+0.76 %) |
| Nov 28 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.46 | 10,000 | 24,600 | 20,000 | 10 K to 20 K (+100.00 %) |
| Nov 27 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.65 | 10,000 | 26,500 | 10,000 | 0 to 10 K |
| Nov 15 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | C | 1.68 | 59,524 | 100,000 | 118,149 | 58.6 K to 118.1 K (+101.53 %) |
| Jul 19 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 4.00 | 128,981 | 515,924 | 128,981 | |
| Jul 02 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.52 | 24,802 | 62,501 | 24,802 | |
| Jul 02 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.52 | 24,802 | 62,501 | 24,802 | |
| Jun 14 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | M | 14.24 | 8,000 | 113,920 | 8,000 | |
| Jan 04 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Option Exercise | A | 4.95 | 6,061 | 30,002 | 6,061 | ||
| May 19 2017 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 5.00 | 12,000 | 60,000 | 12,000 | |
| May 19 2017 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | C | 1.40 | 19,426 | 27,196 | 58,625 | 39.2 K to 58.6 K (+49.56 %) |
Page: 1